Spasm spasticity

1. Introduction
ms are visible, palpable, and painful contractions in a weakened muscle or part of a muscle. Most m
to as nocturnal muscle cramps (NMC), causing sleep disruption and affecting quality of life.

2. Methodology
Inclusion Criteria:
- Adults experiencing muscle spasms or cramps
- Individuals with nocturnal leg cramps (NLC) or repetitive lower extremity muscle activity
- Subjects with relevant comorbidities (e.g., diabetes, heart failure, spinal stenosis)
Exclusion Criteria:
- Individuals with confirmed non-muscle sources of pain
- Subjects without documentation of spasm frequency or treatment outcomes
- Patients with incomplete or confounding clinical data

3. Results of the Research
healthy adults is 50-60%
e 2nd and 3rd trimesters, the incidence ranges from 30-50%
ce muscle cramps more than three times per week, averaging 9 minutes per episode
ronic liver disease have a significantly higher prevalence of muscle cramps
sing magnesium oxide monohydrate (MOMH) showed a significant reduction in nocturnal leg cramp

4. Discussion
te imbalance, fatigue, medications, and certain chronic diseases. True muscle spasms are distinct fro
LSS.

5. Conclusion
scle spasms are benign and idiopathic in nature, and conservative measures remain the first line of
for pharmacological treatment remains limited and inconclusive
ation of underlying causes and prevention strategies (e.g., stretching, hydration) are key
c assessment for deficiencies (e.g., choline, magnesium) may help in managing recurrent spasms
of underlying medical conditions remains critical in symptom reduction and improving quality of life